TransMedics Group

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. 

CEO
Waleed H. Hassanein
CEOWaleed H. Hassanein
Employees
898
Employees898
Headquarters
Andover, Massachusetts
HeadquartersAndover, Massachusetts
Founded
1998
Founded1998
Employees
898
Employees898

TMDX Key Statistics

Market cap
3.12B
Market cap3.12B
Price-Earnings ratio
23.41
Price-Earnings ratio23.41
Dividend yield
Dividend yield
Average volume
645.12K
Average volume645.12K
High today
$90.11
High today$90.11
Low today
$83.61
Low today$83.61
Open price
$84.69
Open price$84.69
Volume
539.99K
Volume539.99K
52 Week high
$156.00
52 Week high$156.00
52 Week low
$60.11
52 Week low$60.11

Stock Snapshot

The current TransMedics Group(TMDX) stock price is $89.98, with a market capitalization of 3.12B. The stock trades at a price-to-earnings (P/E) ratio of 23.41.

As of 2026-09-07, TransMedics Group(TMDX) stock has fluctuated between $83.61 and $90.11. The current price stands at $89.98, placing the stock +7.6% above today's low and -0.1% off the high.

TransMedics Group(TMDX) shares are trading with a volume of 539.99K, against a daily average of 645.12K.

In the last year, TransMedics Group(TMDX) shares hit a 52-week high of $156.00 and a 52-week low of $60.11.

In the last year, TransMedics Group(TMDX) shares hit a 52-week high of $156.00 and a 52-week low of $60.11.

TMDX News

Simply Wall St 2d
The Bull Case For TransMedics Group Could Change Following Its 2026 Guidance Trade-Offs – Learn Why

In the second quarter of 2026, TransMedics Group reported earnings per share of US$0.44, lifted the lower end of its 2026 revenue outlook, but reduced its adjus...

The Bull Case For TransMedics Group Could Change Following Its 2026 Guidance Trade-Offs – Learn Why
Simply Wall St 4d
Is TransMedics Group Undervalued Following Its Earnings Miss And Margin Guidance Cut?

Advertisement TransMedics Group earnings miss and guidance update put renewed focus on growth spending TransMedics Group (TMDX) recently reported second quart...

Is TransMedics Group Undervalued Following Its Earnings Miss And Margin Guidance Cut?

Analyst ratings

67%

of 12 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.